UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hyperkalemia complicating propranolol treatment of an infantile hemangioma

Pediatrics (Evanston), 2010-12, Vol.126 (6), p.e1589-e1593

2010

Volltextzugriff (PDF)

Estrogen Receptor β Inhibits 17β-Estradiol-Stimulated Proliferation of the Breast Cancer Cell Line T47D

Proceedings of the National Academy of Sciences - PNAS, 2004-02, Vol.101 (6), p.1566-1571

2004

Volltextzugriff (PDF)

Dexamethasone induces the expression of metalloproteinase inhibitor TIMP-1 in the murine cerebral vascular endothelial cell line cEND

The Journal of physiology, 2007-05, Vol.580 (3), p.937-949

2007

Volltextzugriff (PDF)

Involvement of Estrogen Receptor β in Terminal Differentiation of Mammary Gland Epithelium

Proceedings of the National Academy of Sciences - PNAS, 2002-11, Vol.99 (24), p.15578-15583

2002

Volltextzugriff (PDF)

Glucocorticoids regulate the human occludin gene through a single imperfect palindromic glucocorticoid response element

Molecular and cellular endocrinology, 2008-11, Vol.295 (1), p.39-47

2008

Volltextzugriff (PDF)

Characterization of the ERβ -/- Mouse Heart

Proceedings of the National Academy of Sciences - PNAS, 2004-09, Vol.101 (39), p.14234-14239

2004

Volltextzugriff (PDF)

Inhibition of Androgen Receptor (AR) Function by the Reproductive Orphan Nuclear Receptor DAX-1

Molecular endocrinology (Baltimore, Md.), 2002-03, Vol.16 (3), p.515-528

2002

Volltextzugriff (PDF)

HES-1, a Novel Target Gene for the Aryl Hydrocarbon Receptor

Molecular pharmacology, 2004-01, Vol.65 (1), p.165-171

2004

Volltextzugriff (PDF)

Two insulin-responsive glucose transporter isoforms and the insulin receptor are developmentally expressed in rabbit preimplantation embryos

Reproduction (Cambridge, England), 2004-11, Vol.128 (5), p.503-516

2004

Volltextzugriff (PDF)

The Anti-estrogenic Effect of All-trans-retinoic Acid on the Breast Cancer Cell Line MCF-7 Is Dependent on HES-1 Expression

The Journal of biological chemistry, 2002-08, Vol.277 (32), p.28376-28379

2002

Volltextzugriff (PDF)

Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD2 antibody ch14.18/CHO

mAbs, 2018-01, Vol.10 (1), p.55-61

2018

Volltextzugriff (PDF)

Feasibility of peripheral blood stem cell collection from sickle cell trait donors with an intensified G‐CSF regimen

European journal of haematology, 2023-11, Vol.111 (5), p.824-830

2023

Volltextzugriff (PDF)

Pineal anlage tumor: clinical and diagnostic features, and rationales for treatment

Journal of neuro-oncology, 2024-01, Vol.166 (2), p.359-368

2024

Volltextzugriff (PDF)

Neuroblastoma patients with high-affinity FCGR2A, -3A and stimulatory KIR 2DS2 treated by long-term infusion of anti-GD2 antibody ch14.18/CHO show higher ADCC levels and improved event-free survival

Oncoimmunology, 2016-11, Vol.5 (11), p.e1235108-e1235108

2016

Volltextzugriff (PDF)

Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial

The lancet oncology, 2024-07, Vol.25 (7), p.922-932

2024

Volltextzugriff (PDF)

Occludin as direct target for glucocorticoid‐induced improvement of blood–brain barrier properties in a murine in vitro system

The Journal of physiology, 2005-06, Vol.565 (2), p.475-486

2005

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of ch14.18/CHO in relapsed/refractory high-risk neuroblastoma patients treated by long-term infusion in combination with IL-2

mAbs, 2016-04, Vol.8 (3), p.604-616

2016

Volltextzugriff (PDF)

Inflammatory response and treatment tolerance of long-term infusion of the anti-GD 2 antibody ch14.18/CHO in combination with interleukin-2 in patients with high-risk neuroblastoma

Pediatric blood & cancer, 2018-06, Vol.65 (6), p.e26967

2018

Volltextzugriff (PDF)

Die Kombinationstherapie infantiler Hämangiome mit gepulstem Farbstofflaser und Nd:YAG-Laser ist wirksam und sicher

Journal der Deutschen Dermatologischen Gesellschaft, 2014-06, Vol.12 (6), p.473-479

2014

Volltextzugriff (PDF)

Abstract 1539: Impact of glioma cell gene expression due to semaphorin expression

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.1539-1539

2011

Volltextzugriff (PDF)

Survival of neuroblastoma patients treated by long-term infusion of anti-GD 2 antibody ch14.18/CHO and killer-cell Ig-like receptor (KIR) genotypes and Fcγ-receptor polymorphisms

Journal of clinical oncology, 2017-03, Vol.35 (7_suppl), p.111-111

2017

Volltextzugriff (PDF)

Abstract CT410: Immune activation, clinical response and survival following long-term infusion of anti-GD2 antibody ch14.18/CHO in combination with interleukin-2 in high-risk neuroblastoma patients

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.CT410-CT410

2014

Volltextzugriff (PDF)

Inflammatory response and treatment tolerance of long‐term infusion of the anti‐GD2 antibody ch14.18/CHO in combination with interleukin‐2 in patients with high‐risk neuroblastoma

Pediatric blood & cancer, 2018-06, Vol.65 (6), p.e26967-n/a

2018

Volltextzugriff (PDF)

Effects of 18-kDa translocator protein knockdown on gene expression of glutamate receptors, transporters, and metabolism, and on cell viability affected by glutamate

Pharmacogenetics and genomics, 2012-08, Vol.22 (8), p.606-619

2012

Volltextzugriff (PDF)

Correlation of killer-cell Ig-like receptor (KIR) haplotypes and Fcγ-receptor polymorphisms with survival of high-risk relapsed/refractory neuroblastoma patients treated by long-term infusion of anti-GD2 antibody ch14.18/CHO

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.10548-10548

2016

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(47)
Berichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hyperkalemia complicating propranolol treatment of an infantile hemangioma

Estrogen Receptor β Inhibits 17β-Estradiol-Stimulated Proliferation of the Breast Cancer Cell Line T47D

Dexamethasone induces the expression of metalloproteinase inhibitor TIMP-1 in the murine cerebral vascular endothelial cell line cEND

Involvement of Estrogen Receptor β in Terminal Differentiation of Mammary Gland Epithelium

Glucocorticoids regulate the human occludin gene through a single imperfect palindromic glucocorticoid response element

Characterization of the ERβ -/- Mouse Heart

Inhibition of Androgen Receptor (AR) Function by the Reproductive Orphan Nuclear Receptor DAX-1

HES-1, a Novel Target Gene for the Aryl Hydrocarbon Receptor

Two insulin-responsive glucose transporter isoforms and the insulin receptor are developmentally expressed in rabbit preimplantation embryos

The Anti-estrogenic Effect of All-trans-retinoic Acid on the Breast Cancer Cell Line MCF-7 Is Dependent on HES-1 Expression

Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD2 antibody ch14.18/CHO

Feasibility of peripheral blood stem cell collection from sickle cell trait donors with an intensified G‐CSF regimen

Pineal anlage tumor: clinical and diagnostic features, and rationales for treatment

Neuroblastoma patients with high-affinity FCGR2A, -3A and stimulatory KIR 2DS2 treated by long-term infusion of anti-GD2 antibody ch14.18/CHO show higher ADCC levels and improved event-free survival

Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial

Occludin as direct target for glucocorticoid‐induced improvement of blood–brain barrier properties in a murine in vitro system

Pharmacokinetics and pharmacodynamics of ch14.18/CHO in relapsed/refractory high-risk neuroblastoma patients treated by long-term infusion in combination with IL-2

Inflammatory response and treatment tolerance of long-term infusion of the anti-GD 2 antibody ch14.18/CHO in combination with interleukin-2 in patients with high-risk neuroblastoma

Die Kombinationstherapie infantiler Hämangiome mit gepulstem Farbstofflaser und Nd:YAG-Laser ist wirksam und sicher

Abstract 1539: Impact of glioma cell gene expression due to semaphorin expression

Survival of neuroblastoma patients treated by long-term infusion of anti-GD 2 antibody ch14.18/CHO and killer-cell Ig-like receptor (KIR) genotypes and Fcγ-receptor polymorphisms

Abstract CT410: Immune activation, clinical response and survival following long-term infusion of anti-GD2 antibody ch14.18/CHO in combination with interleukin-2 in high-risk neuroblastoma patients

Inflammatory response and treatment tolerance of long‐term infusion of the anti‐GD2 antibody ch14.18/CHO in combination with interleukin‐2 in patients with high‐risk neuroblastoma

Effects of 18-kDa translocator protein knockdown on gene expression of glutamate receptors, transporters, and metabolism, and on cell viability affected by glutamate

Correlation of killer-cell Ig-like receptor (KIR) haplotypes and Fcγ-receptor polymorphisms with survival of high-risk relapsed/refractory neuroblastoma patients treated by long-term infusion of anti-GD2 antibody ch14.18/CHO

Suchergebnisse filtern